Van de Walle Stefaan, Dujardin Karl
Int J Cardiol. 2007 Dec 15;123(1):66-8. doi: 10.1016/j.ijcard.2006.11.091. Epub 2007 Feb 8.
Coronary embolism is an uncommon cause of myocardial infarction which should be considered especially in patients with associated conditions like atrial fibrillation, intracardiac prosthesis or infective endocarditis. We present the case of a 64-year-old man with lone paroxysmal AF who sustained an acute anterior wall infarction due to an embolism in the LAD. The patient was being treated with tamoxifen for benign gynaecomastia. The case illustrates some therapeutic problems of embolic myocardial infarction. Rescue PTCA after unsuccessful thrombolysis first resulted in distal embolization in diagonal branches with the need for aggressive anticoagulation. While the final angiographic result was satisfactory, the patient died of an intracranial hemorrhage. We present a short overview of the therapeutic options of coronary embolism and discuss the effect of the selective estrogen receptor modulator tamoxifen on arterial and venous thromboembolic disease which is suggestive of a pathogenic role.
冠状动脉栓塞是心肌梗死的一种罕见病因,尤其在患有心房颤动、心脏内假体或感染性心内膜炎等相关疾病的患者中应予以考虑。我们报告一例64岁男性,患有孤立性阵发性房颤,因左前降支栓塞导致急性前壁梗死。该患者正在接受他莫昔芬治疗良性男性乳房发育症。该病例说明了栓塞性心肌梗死的一些治疗问题。溶栓失败后进行补救性经皮冠状动脉腔内血管成形术(PTCA),首先导致对角支远端栓塞,需要积极抗凝。虽然最终血管造影结果令人满意,但患者死于颅内出血。我们简要概述了冠状动脉栓塞的治疗选择,并讨论了选择性雌激素受体调节剂他莫昔芬对动脉和静脉血栓栓塞性疾病的影响,这提示了其致病作用。